Report: Consumers in dark on physician quality data

Independent and objective data on physician performance are only available for 15 percent of doctors in the U.S., according to a recent report from the non-profit Health Care Incentives Improvement Institute (HCI3).

In its state report card on transparency of physician quality information, only Minnesota and Washington received an A. Maine and California each received a B, while Massachusetts and Wisconsin both earned a C. The rest didn’t perform so well; Missouri, New Mexico, Ohio and Oregon received Ds while the remaining 40 states, plus the District of Columbia, all received failing marks, according to the report.

“Consumers are flying blind when it comes to selecting hospitals and physicians, and the overall quality and affordability of American healthcare won’t be improved until we find a way to solve this problem,” said Francois de Brantes, HCI3 executive director, in a statement. “While the 2014 report shows an improvement in grades in a few states, overall the lack of information to make informed choices is disappointing.”

Read the report

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.